We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $4.25B
1-Year Est. Return 141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$4.25B
AUM Growth
+$1.09B
Cap. Flow
-$109M
Cap. Flow %
-2.57%
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39

Top Buys

Rank Stock Value
1
LGN
Legence Corp
LGN
+$53.3M
2
SXT icon
Sensient Technologies
SXT
+$43.9M
3
IDCC icon
InterDigital
IDCC
+$35.5M
4
ACLS icon
Axcelis
ACLS
+$34.7M
5
TEX icon
Terex
TEX
+$34.1M

Top Sells

Rank Stock Value
1
BE icon
Bloom Energy
BE
+$137M
2
CRDO icon
Credo Technology Group
CRDO
+$94.7M
3
TTMI icon
TTM Technologies
TTMI
+$85.3M
4
FN icon
Fabrinet
FN
+$68.7M
5
STRL icon
Sterling Infrastructure
STRL
+$55.7M

Sector Composition

Rank Sector Weight
1 Technology 27.23%
2 Industrials 24.1%
3 Healthcare 21.93%
4 Financials 9.1%
5 Consumer Discretionary 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LPX icon
226
Louisiana-Pacific
LPX
$4.74B
$47.6K ﹤0.01%
605
– –
HLI icon
227
Houlihan Lokey
HLI
$9.56B
$46.3K ﹤0.01%
345
– –
FFIN icon
228
First Financial Bankshares
FFIN
$4.78B
$40K ﹤0.01%
1,157
– –
COLL icon
229
Collegium Pharmaceutical
COLL
$772M
$38K ﹤0.01%
1,049
-401,703
-100% -$13.7M
MDGL icon
230
Madrigal Pharmaceuticals
MDGL
$12.5B
$37.6K ﹤0.01%
70
-37,584
-100% -$19.3M
WHD icon
231
Cactus
WHD
$5B
$35.9K ﹤0.01%
700
– –
EFSC icon
232
Enterprise Financial Services Corp
EFSC
$2.33B
$34.9K ﹤0.01%
530
– –
MCB icon
233
Metropolitan Bank Holding Corp
MCB
$1.14B
$29.5K ﹤0.01%
299
– –
SMCI icon
234
Super Micro Computer
SMCI
$24.9B
$19.7K ﹤0.01%
671
– –
FWRD icon
235
Forward Air
FWRD
$551M
$7.9K ﹤0.01%
585
– –
OFIX icon
236
Orthofix Medical
OFIX
$379M
$923 ﹤0.01%
101
– –
ACAD icon
237
Acadia Pharmaceuticals
ACAD
$4.8B
– –
-28,637
Closed -$637K
AMT icon
238
American Tower
AMT
$82.8B
– –
-118
Closed -$20.4K
APP icon
239
Applovin
APP
$105B
– –
-1,139
Closed -$453K
BBIO icon
240
BridgeBio Pharma
BBIO
$14.7B
– –
-515,361
Closed -$38.3M
BUSE icon
241
First Busey Corp
BUSE
$2.53B
– –
-1,309
Closed -$33.1K
BYRN icon
242
Byrna Technologies
BYRN
$79.8M
– –
-432,626
Closed -$3.97M
CSGP icon
243
CoStar Group
CSGP
$12.8B
– –
-4,808
Closed -$194K
ENVA icon
244
Enova International
ENVA
$5.81B
– –
-3,507
Closed -$476K
FCNCA icon
245
First Citizens BancShares
FCNCA
$24.9B
– –
-95
Closed -$179K
FOUR icon
246
Shift4
FOUR
$3.49B
– –
-24,044
Closed -$1.05M
IONQ icon
247
IonQ
IONQ
$15.8B
– –
-447,729
Closed -$12.9M
KALV
248
DELISTED
KalVista Pharmaceuticals
KALV
– –
-1,264,023
Closed -$25.4M
KNSL icon
249
Kinsale Capital Group
KNSL
$8.72B
– –
-572
Closed -$195K
MSCI icon
250
MSCI
MSCI
$41.8B
– –
-404
Closed -$218K
7 8 9
10
11

Similar funds

AP
Altarock Partners West Palm Beach, Florida $4.24B AUM 4.82% 1-Year Est. Return
QWP
Quotient Wealth Partners Dallas, Texas $4.24B AUM 17.81% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $4.23B AUM 29.95% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.26B AUM 12.94% 1-Year Est. Return
TFM
Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
CAM
Contour Asset Management New York $4.22B AUM 26.55% 1-Year Est. Return

Emerald Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
  • Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
  • Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
  • Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
  • Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
  • Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.